item.page.files
item.page.type
item.page.type.articleitem.page.version
item.page.version.publishedversionitem.page.date
item.page.ccrights
item.page.use_identifier: https://hdl.handle.net/2445/158574
A new quinoxaline-containing peptide induces apoptosis in cancer cells by autophagy modulation
item.page.journal-title
relationships.isAdvisorOf
item.page.journal-issn
item.page.volume-title
item.page.relation.uri
item.page.abstract
The synthesis of a new small library of quinoxaline-containing peptides is described. After cytotoxic evaluation in four human cancer cell lines, as well as detailed biological studies, it was found that the most active compound, RZ2, promotes the formation of acidic compartments, where it accumulates, blocking the progression of autophagy. Further disruption of the mitochondrial membrane potential and an increase in mitochondrial ROS was observed, causing cells to undergo apoptosis. Given its cytotoxic activity and protease-resistant features, RZ2 could be a potential drug candidate for cancer treatment and provide a basis for future research into the crosstalk between autophagy and apoptosis and its relevance in cancer therapy.
item.page.subject.classification
item.page.subject.other
item.page.citation
citation-export.title
ZAMUDIO VÁZQUEZ, Rubí, et al. A new quinoxaline-containing peptide induces apoptosis in cancer cells by autophagy modulation. Chemical Science. 2015. Vol. 6, num. 4537-4549. ISSN 2041-6520. [consulted: 28 of September of 2026]. Available at: https://hdl.handle.net/2445/158574